UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study

The Journal of infection, 2020-12, Vol.81 (6), p.966-972

2020

Link zum Volltext

Verfügbarkeit prüfen

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial

The lancet respiratory medicine, 2017-05, Vol.5 (5), p.401-411

2017

Link zum Volltext

Verfügbarkeit prüfen

Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19

Frontiers in immunology, 2022-09, Vol.13, p.988685-988685

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

Frontiers in immunology, 2021-07, Vol.12, p.694759-694759

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19

Frontiers in immunology, 2022-05, Vol.13, p.853265-853265

2022

Link zum Volltext

Verfügbarkeit prüfen

Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus

The lancet respiratory medicine, 2020-12, Vol.8 (12), p.e92-e93

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study

The lancet respiratory medicine, 2020-12, Vol.8 (12), p.1192-1200

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease

The Journal of infection, 2019-10, Vol.79 (4), p.357-362

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial

The European respiratory journal, 2018-08, Vol.52 (2), p.1800555

2018

Link zum Volltext

Verfügbarkeit prüfen

Antiviral treatment of severe non-influenza respiratory virus infection

Current opinion in infectious diseases, 2017-12, Vol.30 (6), p.573-578

2017

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care testing for respiratory viruses in adults: The current landscape and future potential

The Journal of infection, 2015-11, Vol.71 (5), p.501-510

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular Point-of-care Testing for Influenza to Improve Early Neuraminidase Inhibitor Treatment and Outcomes in Hospitalized Adults

Clinical infectious diseases, 2019-05, Vol.68 (12), p.2154-2155

2019

Link zum Volltext

Verfügbarkeit prüfen

Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation

The Journal of infection, 2024-01, Vol.88 (1), p.41-47

2024

Link zum Volltext

Verfügbarkeit prüfen

Global extent of chloroquine-resistant Plasmodium vivax

The Lancet infectious diseases, 2015-06, Vol.15 (6), p.630-630

Brendish, Nathan J

2015

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19

The Journal of infection, 2020-10, Vol.81 (4), p.607-613

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of influenza with neuraminidase inhibitors

Current opinion in infectious diseases, 2018-12, Vol.31 (6), p.514-519

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes of Rapid Respiratory Virus Testing in Emergency Departments: A Systematic Review and Meta-Analysis

JAMA internal medicine, 2024-05, Vol.184 (5), p.528

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial

The Lancet infectious diseases, 2023-08, Vol.23 (8), p.945-955

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

The lancet respiratory medicine, 2021-04, Vol.9 (4), p.419-429

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)

BMC infectious diseases, 2017-02, Vol.17 (1), p.128-128, Article 128

2017

Link zum Volltext

Verfügbarkeit prüfen

Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19

The Journal of infection, 2022-04, Vol.84 (4), p.558-565

2022

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death

The Journal of infection, 2021-10, Vol.83 (4), p.458-466

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection

The Journal of infection, 2020-12, Vol.81 (6), p.937-943

2020

Link zum Volltext

Verfügbarkeit prüfen

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department

Infection control and hospital epidemiology, 2022-08, Vol.43 (8), p.979-986

2022

Link zum Volltext

Verfügbarkeit prüfen

Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance

The Journal of infection, 2021-10, Vol.83 (4), p.496-522

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(27)
Infectious Diseases
(18)
Adult
(13)
Female
(12)
Covid-19
(11)
Male
(11)
Influenza
(10)
Aged
(9)
Middle Aged
(9)
Sars-Cov-2
(9)
Antiviral Agents - Therapeutic Use
(7)
Point-Of-Care Testing
(7)
Hospitalization
(6)
Hospitals
(6)
Pandemics
(6)
Respiratory System
(6)
Respiratory Tract Infections - Diagnosis
(6)
Respiratory Tract Infections - Virology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial

Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19

Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study

Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease

Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial

Antiviral treatment of severe non-influenza respiratory virus infection

Point-of-care testing for respiratory viruses in adults: The current landscape and future potential

Molecular Point-of-care Testing for Influenza to Improve Early Neuraminidase Inhibitor Treatment and Outcomes in Hospitalized Adults

Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation

Global extent of chloroquine-resistant Plasmodium vivax

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19

Treatment of influenza with neuraminidase inhibitors

Clinical Outcomes of Rapid Respiratory Virus Testing in Emergency Departments: A Systematic Review and Meta-Analysis

Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)

Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19

SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death

Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department

Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance

Suchergebnisse filtern